Raimar Löbenberg

Raimar Löbenberg

Chairman at DEFENCE THERAPEUTICS INC.

Net worth: 2 M $ as of 2024-03-30

58 year
Consumer Services
Health Technology

Profile

Raimar Löbenberg is the founder of RS Therapeutics, Inc. He currently holds the position of Chairman at Defence Therapeutics Inc and Independent Director at BioNxt Solutions, Inc. He is also the Co-Managing Director at Vektor Pharma TF GmbH.
In addition, he has been a Professor of Pharmacy & Pharmaceutical at the University of Alberta since 2000.
Previously, he served as the President of the Canadian Society for Pharmaceutical Sciences from 2014 to 2015.
Dr. Löbenberg obtained his doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main and his undergraduate degree from The Johannes Gutenberg University of Mainz.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-04-02 5,000,000 ( 4.72% ) 2 M $ 2024-03-30
2023-11-01 100,000 ( 0.22% ) 125 000 $ 2024-03-30

Raimar Löbenberg active positions

CompaniesPositionStart
BIONXT SOLUTIONS INC. Director/Board Member 2018-12-09
DEFENCE THERAPEUTICS INC. Chairman 2021-01-04
University of Alberta Corporate Officer/Principal 1999-12-31
RS Therapeutics, Inc. Founder -
Chief Executive Officer -
All active positions of Raimar Löbenberg

Former positions of Raimar Löbenberg

CompaniesPositionEnd
Canadian Society for Pharmaceutical Sciences President 2014-12-31
See the detail of Raimar Löbenberg's experience

Training of Raimar Löbenberg

Johann Wolfgang Goethe-Universität Frankfurt am Main Doctorate Degree
The Johannes Gutenberg University of Mainz Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Raimar Löbenberg's experience

Connections

100 +

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
BIONXT SOLUTIONS INC.

Health Technology

DEFENCE THERAPEUTICS INC.

Health Technology

Private companies3
Canadian Society for Pharmaceutical Sciences

RS Therapeutics, Inc.

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Raimar Löbenberg